Canada House Wellness Group Announces Exclusive Genetics Agreement With InPlanta Biotechnology

Published: June 5, 2020

Canada House Wellness Group Announces Exclusive Genetics Agreement With InPlanta Biotechnology

Canada House Wellness Group Inc., a fully integrated medical cannabis company, has entered into an exclusive genetic licensing agreement with InPlanta Biotechnology Inc. to bring VetStar Day™ and VetStar Night™ strains to the licensed facility of its wholly owned subsidiary, Abba Medix Corp., in Pickering Ontario.  InPlanta, a leading Cannabis R&D company based in Lethbridge, Alberta, will partner with Canada House and Abba on the production of a Veteran focused line of Cannabis products to be offered exclusively to registered Abba patients.

VetStar Day and VetStar Night 

In 2013, Dr. Darryl Hudson began assessing Cannabis varieties for their efficacy on Veterans battling PTSD. Through this research, it was observed that high THC Kush varieties with specific terpene profiles were effective for reducing the symptoms of both PTSD and pain, as well as alleviating the “hypervigilance syndrome” that is prevalent in many who have fought in recent wars.  InPlanta, in collaboration with top breeders in British Columbia, enhanced these properties through traditional breeding efforts.  Veterans Kush is a hybrid of B.C. Rockstar (B.C. Rockbud x Bubba) and Master Kush then backcrossed to Rockstar to obtain a specific terpene profile.  InPlanta selected both low and high myrcene varieties in order to create the “Veterans Day” and “Veterans Night” lines with reduced and enhanced sedative effects, respectively.  In partnership with CHV, these lines will be available for sale exclusively to patients registered with Abba. VetStar Day™ and VetStar Night™ are currently being grown in Abba’s Licensed facility and are expected to be available for sale in September, 2020.

“As a company focused on the development of Cannabis varieties with maximum medicinal benefits, we are thrilled to be working alongside Chris and his team to bring these specifically designed Cannabis medications to those who need them the most,” said Dr. Igor Kovalchuk, Chief Science Officer of InPlanta who has recently garnered international attention for his research on Cannabis as an application for the treatment of COVID-19. “These strains were bred and perfected over many years specifically for Veterans. Canada House’s commitment to the health and wellness of its patients, specifically the Veteran community, makes them the perfect partner for us.”

“We are thrilled to have secured the exclusive right to bring VetStar genetics to market.  We are a Veteran focused company first and are committed to providing the highest quality genetics to our important registered patient base,” said Chris Churchill-Smith, CEO, Canada House.  “At Abba, we are listening to our patients and are focused on committed to taking this feedback seriously and building out a menu of the highest quality products and formats tailored specifically to the wants and needs of our patients.  VetStar is simply the next step in our strategic plan of providing the leading assortment of Abba and third-party products to Abba’s registered patients.  To this end, we very much look forward to sharing further news on the build out of our menu over the coming weeks and months, and would like to commend Igor and Darryl for their wonderful work.”

InPlanta Biotechnology Inc. is a leading Cannabis Research & Development company based in Lethbridge, Alberta, lead by Dr. Darryl Hudson and Dr. Igor Kovalchuk who recently attracted international attention through work on Cannabis as a potential therapy in the management of COVID-19.

Canada House Wellness Group Inc. is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis